Bloomberg Businessweek (North America)
$265m
Astrazeneca sells its gout drug. Ironwood Pharmaceuticals bought the U.S. rights to Zurampic, a newly approved treatment. The deal gives Astrazeneca royalties on future sales.
Bloomberg Businessweek (North America)
Astrazeneca sells its gout drug. Ironwood Pharmaceuticals bought the U.S. rights to Zurampic, a newly approved treatment. The deal gives Astrazeneca royalties on future sales.